23 September 2024
23 September 2024
The agreement for the use of NuProbe’s NGS panel will support the accelerated development of Angle’s pan-cancer assay.
Meeting the EU’s MDR requirements presents considerable challenges for CROs, their clients, and the European medtech space at large.
Measuring the objective response rate to the treatment will be the study's primary efficacy objective.
Cercle will use the funding to improve its AI-driven platform and expand it beyond the fertility market.
This test detects the presence of two biomarkers, indicating a potential transformation into a cancerous state.
The next research phase aims to understand the genetic factors influencing lipids and their implications for metabolic diseases.
The PromarkerEso diagnostic blood test is intended for early detection and treatment of EAC, a form of oesophageal cancer.
The Aurora EV-ICD’s ability to offer pacing is a critical differentiator.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Companies in the healthcare sector are investing in the technologies of the future right now. GlobalData's latest thematic report looks ahead to 2035 and beyond, identifying the key innovations that will revolutionize the industry and profiling the start-ups leading the charge. The report also evaluates the global outlook for the sector and how various challenges must be addressed for these trends to reach their full potential.
Companies in the healthcare sector are investing in the technologies of the future right now. GlobalData's latest thematic report looks ahead to 2035 and beyond, identifying the key innovations that will revolutionize the industry and profiling the start-ups leading the charge. The report also evaluates the global outlook for the sector and how various challenges must be addressed for these trends to reach their full potential.
Companies in the healthcare sector are investing in the technologies of the future right now. GlobalData's latest thematic report looks ahead to 2035 and beyond, identifying the key innovations that will revolutionize the industry and profiling the start-ups leading the charge. The report also evaluates the global outlook for the sector and how various challenges must be addressed for these trends to reach their full potential.
Companies in the healthcare sector are investing in the technologies of the future right now. GlobalData's latest thematic report looks ahead to 2035 and beyond, identifying the key innovations that will revolutionize the industry and profiling the start-ups leading the charge. The report also evaluates the global outlook for the sector and how various challenges must be addressed for these trends to reach their full potential.
Companies in the healthcare sector are investing in the technologies of the future right now. GlobalData's latest thematic report looks ahead to 2035 and beyond, identifying the key innovations that will revolutionize the industry and profiling the start-ups leading the charge. The report also evaluates the global outlook for the sector and how various challenges must be addressed for these trends to reach their full potential.
Companies in the healthcare sector are investing in the technologies of the future right now. GlobalData's latest thematic report looks ahead to 2035 and beyond, identifying the key innovations that will revolutionize the industry and profiling the start-ups leading the charge. The report also evaluates the global outlook for the sector and how various challenges must be addressed for these trends to reach their full potential.
Give your business an edge with our leading industry insights.
